FDA approves Mylan treatment for hypertension

Alaric DeArment

10/22/2008

PITTSBURGH The Food and Drug Administration has granted tentative approval to Mylan for its generic version of Daiichi Sankyo’s hypertension drug Benicar, Mylan announced Wednesday.

The drug, olmesartan medoxomil and hydrochlorothiazide tablets, will be available in dosages of 20 mg/12.5 mg, 40 mg/12.5 mg and 40 mg/25 mg.

Mylan filed the application last Feburary and said it is probably the first company to file a complete application for a generic version of Daiichi Sankyo’s drug.

CVS Weight Management program improves health outcomes, lowers costs

As of Feb. 1, the CVS Weight Management program is available to more than 3.5 million CVS Caremark plan members.

CVS Health to open smaller format stores

Each location will average less than 5,000 square feet and will feature a full-service pharmacy with limited over-the-counter products available for purchase.

Walgreens buyout reportedly could result in three divisions

Walgreens’ three core segments—U.S. pharmacy retailer Walgreens, U.K.-based Boots and specialty unit Shields Health Solutions—could become three independent divisions, per a report.

Ulta Beauty sets date for experiential beauty event

Ulta Beauty World will take place on April 26 in San Antonio, Texas.

Costco to raise hourly pay, reaches tentative agreement with union

Costco also is adding vacation time for new employees during their first year and giving workers with 30 years of employment an additional week of time off, per a CNN report.